Young-kyu Kim

Chuncheon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Karyotype and B chromosome variation in Lilium amabile Palibin.

Karyotype and B chromosome variation in Lilium amabile Palibin.

Journal: Genes & genomics
Published: November 07, 2018

Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.

Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.

Journal: World journal of transplantation
Published: December 22, 2015

Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection.

Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection.

Journal: Disease markers
Published: June 09, 2015

Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.

Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.

Journal: Transplantation
Published: April 24, 2015

Anti-Inflammatory Action of an Antimicrobial Model Peptide That Suppresses the TRIF-Dependent Signaling Pathway via Inhibition of Toll-Like Receptor 4 Endocytosis in Lipopolysaccharide-Stimulated Macrophages.

Anti-Inflammatory Action of an Antimicrobial Model Peptide That Suppresses the TRIF-Dependent Signaling Pathway via Inhibition of Toll-Like Receptor 4 Endocytosis in Lipopolysaccharide-Stimulated Macrophages.

Journal: PloS one
Published: January 11, 2015

Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.

Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: December 06, 2014

Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.

Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab.

Journal: Transplant immunology
Published: September 20, 2014

Pretransplant absolute monocyte count in peripheral blood predicts posttransplant tumor prognosis in patients undergoing liver transplantation for hepatocellular carcinoma.

Pretransplant absolute monocyte count in peripheral blood predicts posttransplant tumor prognosis in patients undergoing liver transplantation for hepatocellular carcinoma.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: June 13, 2014

Prognostic significance of preoperative peripheral blood monocyte ratio in patients with hepatocellular carcinoma.

Prognostic significance of preoperative peripheral blood monocyte ratio in patients with hepatocellular carcinoma.

Journal: World journal of surgery
Published: April 03, 2014

Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions.

Graft-to-recipient weight ratio lower to 0.7% is safe without portal pressure modulation in right-lobe living donor liver transplantation with favorable conditions.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: January 28, 2014

ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.

ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.

Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: October 14, 2013

(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.

(18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.

Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: October 31, 2012
Showing 1-12 of 16

Last Updated: 09/26/2026